No takes yet. Share an insight, caveat, or question.
This perspective discusses the clinical heterogeneity of hypertrophic cardiomyopathy and addresses its historical reputation as a disease with a universally grim prognosis.
Maron et al. (2017) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: